Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aveanna Healthcare Holdings (AVAH) Capital Expenditures (2020 - 2026)

Aveanna Healthcare Holdings (AVAH) has disclosed Capital Expenditures for 6 consecutive years, with $2.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Capital Expenditures fell 8.77% year-over-year to $2.0 million, compared with a TTM value of $7.0 million through Sep 2025, up 10.49%, and an annual FY2024 reading of $6.3 million, up 3.32% over the prior year.
  • Capital Expenditures was $2.0 million for Q3 2025 at Aveanna Healthcare Holdings, up from $1.1 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $4.0 million in Q2 2022 and bottomed at $1.1 million in Q3 2023.
  • Average Capital Expenditures over 5 years is $2.0 million, with a median of $2.0 million recorded in 2022.
  • The sharpest move saw Capital Expenditures tumbled 59.96% in 2023, then skyrocketed 96.36% in 2024.
  • Year by year, Capital Expenditures stood at $2.7 million in 2021, then increased by 20.56% to $3.2 million in 2022, then crashed by 51.2% to $1.6 million in 2023, then decreased by 2.49% to $1.5 million in 2024, then surged by 32.05% to $2.0 million in 2025.
  • Business Quant data shows Capital Expenditures for AVAH at $2.0 million in Q3 2025, $1.1 million in Q2 2025, and $2.3 million in Q1 2025.